Patrick Legembre

Also affiliated with Centre National de la Recherche Scientifique, Inserm, Institute Cancer De La Loire Lucien Neuwirth, Contrôle de la Réponse Immune B et Lymphoproliférations, Centre International de Recherche en Infectiologie, Université de Limoges

Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism”.

CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism

iScience(2021)10.1016/j.isci.2021.103538

N/A

0DataRank · unranked

24 citations

Justine Pollet, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Marcus E. Peter, Patrick Legembre +1 more

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

iScience(2021)10.1016/j.isci.2021.103348

N/A

0DataRank · unranked

20 citations

Jean‐Philippe Guégan, Christophe Ginestier, Assia Chaïbi, Alban Bessede, Emmanuelle Charafe‐Jauffret +14 more

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Nature Communications(2025)10.1038/s41467-025-60990-0

N/A

0DataRank · unranked

6 citations

Tanmoy Mondal, Francis Freenor, Mehr Shaheed, Oliver Pang, Daniel Bedinger +6 more